Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Dosing our first patient in the VAN-2401 phase 1 trial is an important milestone in the advancement of KH658 by exploring the ...

Sunir Garg, MD, a professor of ophthalmology at Wills Eye Hospital and partner with Mid-Atlantic Retina, discussed with Modern Retina one significant challenge in ophthalmological procedures: patient ...

Katherine Talcott, a retina specialist at Cole Eye Institute at the Cleveland Clinic, presented at the Retinal World Congress 2025 meeting. In her presentation and in her conversation with Modern ...

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic atrophy linked to AMD. Seemi Khan, MD, MPH, MBA, Chief Medical Officer of ...

At Retina World Congress 2025, Dilsher S. Dhoot, MD, shares updates on the HELIOS trial and the potential future of tyrosine kinase inhibitors (TKIs). At the Retina World Congress 2025 in Lauderdale, ...

The Retinal Genix plans to use the facility to further the development of its DNA/RNA/GPS Pharmaco-Genetic Mapping platform. RetinalGenix has signed a new laboratory lease agreement with life science ...

According to Dr. Danzig, the DIAMOND trial demonstrates efficacy of OCS-01, a topical drop, in patients with diabetic macular edema. Carl Danzig, MD, director of vitreo-retinal services at the Rand ...

Carl D. Regillo, MD, Director of the Retina Service at Wills Eye Hospital and partner at Mid Atlantic Retina, met with Modern Retina at the 2025 Retina World Congress meeting held in Fort Lauderdale, ...

The OcuMet Beacon is a proprietary, noninvasive tool for assessing retinal health. The company said it will be available on the US market for use in clinics and healthcare institutions. The US Food ...